HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 87 filers reported holding HARVARD BIOSCIENCE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $95,000 | +37.7% | 22,187 | -3.5% | 0.00% | – |
| Q3 2020 | $69,000 | -6.8% | 23,000 | -4.2% | 0.00% | – |
| Q2 2020 | $74,000 | -80.6% | 24,000 | -66.9% | 0.00% | – |
| Q3 2018 | $381,000 | -78.1% | 72,592 | -77.7% | 0.00% | -100.0% |
| Q2 2018 | $1,742,000 | +4.9% | 325,580 | -1.7% | 0.00% | 0.0% |
| Q1 2018 | $1,660,000 | +70.6% | 331,329 | +12.4% | 0.00% | – |
| Q4 2017 | $973,000 | -11.9% | 294,729 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $1,105,000 | +46.9% | 294,729 | 0.0% | 0.00% | – |
| Q2 2017 | $752,000 | +9300.0% | 294,729 | +18436.4% | 0.00% | – |
| Q3 2013 | $8,000 | 0.0% | 1,590 | 0.0% | 0.00% | – |
| Q2 2013 | $8,000 | – | 1,590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |